Skip to content
Monday, March 20, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • Pharmacosmos expands global reach with launch of Monofer in Japanese market
  • Saudi retail pharmacy chain Nahdi posts US$236 million net profit in Q4
  • Saudi healthtech startup Aumet snaps up US$7M in a pre-Series A funding round
  • Cosmos Health expands telehealth services with acquisition of ZipDoctor
  • Pear Therapeutics considers sale and other options to maximize shareholder value
  • UAE-based medical school MBRU earns top-level institutional accreditation
  • Pfizer recalls over 4 million packages of prescription migraine medicine voluntarily
  • Enzo Biochem agrees to sell clinical laboratory services business to LabCorp
  • Samsung Biologics invests in capacity expansion with fifth plant
  • Gulf Medical University marks World Sleep Day with an array of activities
You are here
  • Home
  • Eli Lilly

Tag: Eli Lilly

UCB and Eli Lilly lead US$52M funding round for innovative RNA Biotech startup

14 March 202314 March 2023

USA — Belgian biopharmaceutical company UCB and American pharmaceutical giant Eli Lilly have led a US$52 million funding round for RNA biotech startup Switch Therapeutics for its conditionally activated siRNA…

Read More

Lawmakers seek to make insulin affordable with US$20 per vial price limit

10 March 202312 March 2023

USA — Senator Bernie Sanders, Chair of the Senate Health Committee, has introduced a new bill alongside a companion bill in the House that aims to set the price of…

Read More

Lilly takes steps to make insulin more affordable with price cuts and cost cap expansion

9 March 202310 March 2023

USA — Eli Lilly is set to reduce insulin prices and expand cost cap for insured patients, offering relief to those with diabetes who have to pay high annual costs…

Read More

FDA approves Eli Lilly’s drug for advanced mantle cell lymphoma, to retail at US$21,000 per month

29 January 202330 January 2023

USA — The US Food and Drug Administration (FDA) has approved Eli Lilly and Co.’s drug (pirtobrutinib) for the treatment of a rare form of blood cancer. The indication aims…

Read More

Lilly to invest US$450M in manufacturing plant to boost diabetes drug production

27 January 202330 January 2023

USA — Eli Lilly has announced that it will invest US$450 million in a North Carolina manufacturing plant to meet the rising demand for its diabetes drugs Mounjaro and Trulicity.…

Read More

AbbVie and Eli Lilly quit drug pricing agreement with NHS over increasingly punitive revenue clawbacks

17 January 202319 January 2023

UK — AbbVie and Eli Lilly and Company (Lilly) have shocked the UK Government by withdrawing from the voluntary medicines pricing agreement in response to increasingly harsh revenue clawbacks. The…

Read More

Eli Lilly ends insulin pump collaboration with Ypsomed to focus on its diabetes platform

11 December 202213 December 2022

USA — Eli Lilly and Co. has decided to end its joint project with Ypsomed to enter the US insulin pump market and instead focus on its diabetes offerings. In…

Read More

Eli Lilly launches therapy for early-stage breast cancer in India

25 November 202225 November 2022

INDIA —Eli Lilly and Company (India) Pvt. Ltd. has announced the introduction of the new indication for Ramiven (abemaciclib), a product to treat early stage breast cancer following approval from…

Read More

FDA approves Lilly’s Rezvoglar as second interchangeable insulin product

21 November 202221 November 2022

USA — TheU.S Food and Drug Administration (FDA) has designated Eli Lilly’s Rezvoglar as “interchangeable” with Sanofi’s Lantus, making it the second insulin biosimilar to receive the prestigious designation. Rezvoglar…

Read More

Eli Lilly seeks to expand gene therapy portfolio through US$487M Akouos buyout

19 October 202219 October 2022

USA — Eli Lilly and Company is set to acquire Akouos, a developer of viral gene therapies for the treatment of inner ear conditions, including sensorineural hearing loss as the…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • Pharmacosmos expands global reach with launch of Monofer in Japanese market
  • Saudi retail pharmacy chain Nahdi posts US$236 million net profit in Q4
  • Saudi healthtech startup Aumet snaps up US$7M in a pre-Series A funding round
  • Cosmos Health expands telehealth services with acquisition of ZipDoctor
  • Pear Therapeutics considers sale and other options to maximize shareholder value

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

LATEST TWEETS

HealthCare Middle East & Africa Follow

No. 1 magazine that showcases the people, businesses and market trends in the pharmaceuticals, healthcare and biotech sectors in Africa, Middle East & the World

HealthCareAfro
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Gulf Pharmaceutical Industries @JulpharUAE has appointed Mr. Basel Ziyadeh as the new Chief Executive Officer of its manufacturing business

https://t.co/8AFhARFMmO

#appointments #healthcare #leadership #middleeast #UAE #pharmaceuticals #pharma #manufacturing #Sustainability

Reply on Twitter 1626130056736276482 Retweet on Twitter 1626130056736276482 Like on Twitter 1626130056736276482 1 Twitter 1626130056736276482
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Santechture has secured an undisclosed amount of funding from Gulf Capital (GC) and @ShorooqPartners to further develop its platform, expand its services, and grow its team

https://t.co/pffgXv4Dii

#Funding #Health #technologies #UAE #SaudiArabia #MiddleEast #DiGiTALhealth

Reply on Twitter 1626127995068104707 Retweet on Twitter 1626127995068104707 1 Like on Twitter 1626127995068104707 1 Twitter 1626127995068104707
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Moroccan drug maker Laprophan has entered into an exclusive cooperation agreement with @SinopharmIntl for the production of medicines

https://t.co/XqJU3BADf3

#healthcare #manufacturing #pharmaceuticals #medicines #Africa #partnerships #Health #Morocco #China #PublicHealth

Reply on Twitter 1626125115074449408 Retweet on Twitter 1626125115074449408 Like on Twitter 1626125115074449408 Twitter 1626125115074449408
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

Discovery Health launches new affordable private healthcare in partnership with Clicks and Auto & General

https://t.co/J1fPrRSf2X

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory

Reply on Twitter 1626103265409781761 Retweet on Twitter 1626103265409781761 Like on Twitter 1626103265409781761 3 Twitter 1626103265409781761
healthcareafro HealthCare Middle East & Africa @healthcareafro ·
February 16, 2023

President William Ruto officially commissions the @AarHospital

https://t.co/Z7bGiyAUHe

#digitalhealth #healthtech #innovation #hospitals #healthscience #technology #Vaccines #pharmaceuticals #manufacturing #healthcare #regulatory #health #medical #hospital

Reply on Twitter 1626102988266962945 Retweet on Twitter 1626102988266962945 2 Like on Twitter 1626102988266962945 2 Twitter 1626102988266962945
Load More...

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.